Science
In a mere nine months, Eli Lilly accomplished an unprecedented feat: The drug giant took a blood sample from one of the first U.S. patients to recover from Covid-19, identified an antibody that could fight the virus, and created a version of the antibody to treat people with the disease. Riley Griffin spoke to Lilly's CEO David Ricks about the challenges facing the company and its new treatment amid the worsening pandemic.
See omnystudio.com/listener for privacy information.
More Episodes
The One-Two Punch to Black America
2020-04-16
2020-04-16
A Covid Early Warning Sign
2020-04-15
2020-04-15
Apple and Amazon vs. the Virus
2020-04-14
2020-04-14
What Happened to the CDC?
2020-04-13
2020-04-13
How It All Started
2020-04-10
2020-04-10
Hunting For the Virus in Sewage
2020-04-09
2020-04-09
A Mental Health Crisis Worsens
2020-04-08
2020-04-08
How to Wear a Mask
2020-04-07
2020-04-07
This is How We End It
2020-04-06
2020-04-06
What Germany Did Right
2020-04-03
2020-04-03
The Case For Writing Every American a Check
2020-04-02
2020-04-02
When Will We Have a Vaccine?
2020-04-01
2020-04-01
When You Can't Go See the Doctor
2020-03-31
2020-03-31
This is How the Virus Kills
2020-03-30
2020-03-30
Prognosis Daily: The Coronavirus Detectives
2020-03-27
2020-03-27
Special Episode: Understanding Pandemics
2020-03-26
2020-03-26
Announcing Prognosis Daily: Coronavirus
2020-03-24
2020-03-24
Superbugs' Natural Predator (Rebroadcast)
2020-02-27
2020-02-27
Get this podcast on your
phone, FREE
